Fen Guo

First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study

Xiaofeng Chen, Hao Xu, Xiaobing Chen et al. · Signal Transduction and Targeted Therapy · 2024 · 43 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13

At-Risk Genomic Findings for Pediatric-Onset Disorders From Genome Sequencing vs Medically Actionable Gene Panel in Proactive Screening of Newborns and Children

Jorune Balciuniene, Ruby Liu, Lora Jh Bean et al. · JAMA Network Open · 2023 · 25 citations · Full text

Life Sciences, Genetics, Pediatrics +17

Protective effects of irigenin against <scp>1‐methyl‐4‐phenylpyridinium</scp>‐induced neurotoxicity through regulating the Keap1/Nrf2 pathway

Fen Guo, Xiaoxue Wang, Xinxin Liu · Phytotherapy Research · 2020 · 20 citations

Life Sciences, Pharmacology, Toxicology +17

Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A retrospective study

Ying Feng, Liyu Wang, Fen Guo et al. · Heliyon · 2024 · 10 citations · Full text

Medicine, Immunology, Oncology +17